Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba

Michael T. Osterholm; Cristina Rabadán-Diehl; Joshua Anzinger; Maria Elena Bottazzi; Celia Christie-Samuels; Ngozi Erondu; Jeanne Marrazzo; Sandra Milan; Peter Kojo Quashie; Thomas Schwaab; David Williams

doi:10.37757/MR2022.V24.N3-4.13

Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba

Michael T. Osterholm
, Cristina Rabadán-Diehl
, Joshua Anzinger
, Maria Elena Bottazzi
, Celia Christie-Samuels
, Ngozi Erondu
, Jeanne Marrazzo
, Sandra Milan
, Peter Kojo Quashie
, Thomas Schwaab
, David Williams

West African Center for Cell Biology of Infectious Pathogens

Public Health
The University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP)
National Institute of Health
United States Department of Health and Human Services
The University of the West Indies
The University Hospital of the West Indies
Baylor College of Medicine
The Global Institute for Disease Elimination (GLIDE)
University of Alabama at Birmingham
Genentech Inc.
Roswell Park Cancer Institute
Harvard T.H. Chan School of Public Health
Harvard University

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.

Original language	English
Journal	MEDICC Review
Volume	24
Issue number	3-4
DOIs	https://doi.org/10.37757/MR2022.V24.N3-4.13
Publication status	Published - Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.37757/MR2022.V24.N3-4.13

Cite this

@article{3033609982a14b2ea1168b2108eb2551,

title = "Cuba{\textquoteright}s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba",

abstract = "In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba{\textquoteright}s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.",

author = "Osterholm, \{Michael T.\} and Cristina Rabad{\'a}n-Diehl and Joshua Anzinger and Bottazzi, \{Maria Elena\} and Celia Christie-Samuels and Ngozi Erondu and Jeanne Marrazzo and Sandra Milan and Quashie, \{Peter Kojo\} and Thomas Schwaab and David Williams",

year = "2022",

month = jul,

doi = "10.37757/MR2022.V24.N3-4.13",

language = "English",

volume = "24",

journal = "MEDICC Review",

issn = "1555-7960",

publisher = "MEDICC Medical Education Cooperation with Cuba",

number = "3-4",

}

TY - JOUR

T1 - Cuba’s COVID-19 Vaccine Enterprise

T2 - Report from a High-Level Fact-Finding Delegation to Cuba

AU - Osterholm, Michael T.

AU - Rabadán-Diehl, Cristina

AU - Anzinger, Joshua

AU - Bottazzi, Maria Elena

AU - Christie-Samuels, Celia

AU - Erondu, Ngozi

AU - Marrazzo, Jeanne

AU - Milan, Sandra

AU - Quashie, Peter Kojo

AU - Schwaab, Thomas

AU - Williams, David

PY - 2022/7

Y1 - 2022/7

N2 - In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.

AB - In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.

UR - https://www.scopus.com/pages/publications/85146265083

U2 - 10.37757/MR2022.V24.N3-4.13

DO - 10.37757/MR2022.V24.N3-4.13

M3 - Article

AN - SCOPUS:85146265083

SN - 1555-7960

VL - 24

JO - MEDICC Review

JF - MEDICC Review

IS - 3-4

ER -

Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this